//www.igerbera.com/journals/jamadermatology The Most Cited articles published by JAMA Dermatology en-us Tue, 07 Mar 2023 03:43:37 GMT Tue, 07 Mar 2023 03:43:37 GMT Silverchair jamams@jamanetwork.org support@www.igerbera.com //www.igerbera.com/journals/jamadermatology/fullarticle/2766772 Sat, 01 Aug 2020 00:00:00 GMT This randomized clinical trial investigates the efficacy and safety of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis. 156 8 863 873 10.1001/jamadermatol.2020.1406 2766772 //www.igerbera.com/journals/jamadermatology/fullarticle/2761466 Wed, 01 Apr 2020 00:00:00 GMT This phase 2b, placebo-controlled, randomized clinical trial evaluates the efficacy and safety of lebrikizumab, a novel, high-affinity, monoclonal antibody targeting interleukin (IL)–13 that selectively prevents formation of the IL-13Rα1/IL-4Rα heterodimer receptor signaling complex, in adults with moderate to severe atopic dermatitis. 156 4 411 420 10.1001/jamadermatol.2020.0079 2761466 //www.igerbera.com/journals/jamadermatology/fullarticle/2771084 Tue, 01 Dec 2020 00:00:00 GMT This randomized clinical trial assesses the efficacy and safety of 4 mg and 2 mg of baricitinib in combination with background topical corticosteroid therapy in adults with moderate to severe AD who previously had an inadequate response to topical corticosteroid therapy. 156 12 1333 1343 10.1001/jamadermatol.2020.3260 2771084 //www.igerbera.com/journals/jamadermatology/fullarticle/2782803 Wed, 01 Sep 2021 00:00:00 GMT This randomized clinical trial assesses the safety and efficacy of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis. 157 9 1047 1055 10.1001/jamadermatol.2021.3023 2782803 //www.igerbera.com/journals/jamadermatology/fullarticle/2767774 Tue, 01 Sep 2020 00:00:00 GMT This case series describes 31 patients, most of them teenagers or young adults, who presented with chilblains during the COVID-19 pandemic. 156 9 998 1003 10.1001/jamadermatol.2020.2368 2767774 //www.igerbera.com/journals/jamadermatology/fullarticle/2779643 Tue, 01 Jun 2021 00:00:00 GMT This case-series study describes the clinical course and histopathologic examination findings for delayed localized cutaneous injection-site reactions to the Moderna COVID-19 vaccine. 157 6 716 720 10.1001/jamadermatol.2021.1214 2779643 //www.igerbera.com/journals/jamadermatology/fullarticle/2763686 Mon, 01 Jun 2020 00:00:00 GMT This randomized clinical trial evaluates the safety and efficacy of risankizumab use for 2 years in patients with moderate to severe plaque psoriasis. 156 6 649 658 10.1001/jamadermatol.2020.0723 2763686 //www.igerbera.com/journals/jamadermatology/fullarticle/2773121 Mon, 01 Feb 2021 00:00:00 GMT This retrospective case series describes a systematic assessment of 40 patients with chilblain-like lesions durring the coronavirus 2019 pandemic and examines the association of these lesions with a viral-induced type I interferonopathy. 157 2 202 206 10.1001/jamadermatol.2020.4324 2773121 //www.igerbera.com/journals/jamadermatology/fullarticle/2765614 Wed, 01 Jul 2020 00:00:00 GMT This case report describes a 48-year-old man who presented with a rash on the buttocks, popliteal fossae, proximal anterior thighs, and lower abdomen following the onset of a fever. 156 7 820 822 10.1001/jamadermatol.2020.1741 2765614 //www.igerbera.com/journals/jamadermatology/fullarticle/2760694 Wed, 01 Apr 2020 00:00:00 GMT This systematic review and meta-analysis evaluates the association between cancer and psoriasis or psoriatic arthritis. 156 4 421 429 10.1001/jamadermatol.2020.0024 2760694 //www.igerbera.com/journals/jamadermatology/fullarticle/2765026 Mon, 01 Jun 2020 00:00:00 GMT This systematic review and network meta-analysis compares the effectiveness and safety of systemic immunomodulatory treatments for adult patients with atopic dermatitis. 156 6 659 667 10.1001/jamadermatol.2020.0796 2765026 //www.igerbera.com/journals/jamadermatology/fullarticle/2765613 Wed, 01 Jul 2020 00:00:00 GMT This case report describes an elderly patient who developed a squamous and erythematous periumbilical patch followed by digitate scaly thin plaques and papular lesions in conjunction with severe acute respiratory syndrome coronavirus 2 infection. 156 7 819 820 10.1001/jamadermatol.2020.1704 2765613 //www.igerbera.com/journals/jamadermatology/fullarticle/2765025 Mon, 01 Jun 2020 00:00:00 GMT This review of 2 randomized clinical trials assesses the safety and efficacy of topical clascoterone cream, 1%, a novel androgen receptor inhibitor for acne treatment. 156 6 621 630 10.1001/jamadermatol.2020.0465 2765025 //www.igerbera.com/journals/jamadermatology/fullarticle/2762711 Fri, 01 May 2020 00:00:00 GMT This qualitative study examines how the use of artificial intelligence as a screening tool is perceived by patients receiving care in a dermatology clinic. 156 5 501 512 10.1001/jamadermatol.2019.5014 2762711 //www.igerbera.com/journals/jamadermatology/fullarticle/2767773 Tue, 01 Sep 2020 00:00:00 GMT 这种情况下系列描述了20名儿童和adolescents who presented with new-onset acral inflammatory lesions during the COVID-19 pandemic. 156 9 992 997 10.1001/jamadermatol.2020.2340 2767773 //www.igerbera.com/journals/jamadermatology/fullarticle/2773994 Mon, 01 Feb 2021 00:00:00 GMT This case series describes the mucocutaneous findings seen in children with multisystem inflammatory syndrome in children during the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City in 2020. 157 2 207 212 10.1001/jamadermatol.2020.4779 2773994 //www.igerbera.com/journals/jamadermatology/fullarticle/2768252 Thu, 01 Oct 2020 00:00:00 GMT This case series describes the appearance of enanthem (oral cavity lesions) in patients with COVID-19. 156 10 1134 1136 10.1001/jamadermatol.2020.2550 2768252 //www.igerbera.com/journals/jamadermatology/fullarticle/2766014 Sat, 01 Aug 2020 00:00:00 GMT This case series evaluates the clinical response to treatment with the interleukin 17 antagonist secukinumab in patients with Netherton syndrome. 156 8 907 911 10.1001/jamadermatol.2020.1019 2766014 //www.igerbera.com/journals/jamadermatology/fullarticle/2763192 Fri, 01 May 2020 00:00:00 GMT 这个横断面研究考察了发病率of melanoma in men vs women between differing geographic locations, ages, and anatomic sites. 156 5 553 560 10.1001/jamadermatol.2020.0470 2763192 //www.igerbera.com/journals/jamadermatology/fullarticle/2780049 Sun, 01 Aug 2021 00:00:00 GMT This systematic review and meta-analysis estimates worldwide hidradenitis suppurativa prevalence. 157 8 924 931 10.1001/jamadermatol.2021.1677 2780049 //www.igerbera.com/journals/jamadermatology/fullarticle/2781378 Sun, 01 Aug 2021 00:00:00 GMT This cross-sectional study uses data from the National Health and Nutrition Examination Survey to assess the prevalence of psoriasis in adults in the US and how it has changed since 2003. 157 8 940 946 10.1001/jamadermatol.2021.2007 2781378 //www.igerbera.com/journals/jamadermatology/fullarticle/2781364 Sun, 01 Aug 2021 00:00:00 GMT This cohort study examines cutaneous reactions in hospital employees who received messenger RNA COVID-19 vaccination. 157 8 1000 1002 10.1001/jamadermatol.2021.2114 2781364 //www.igerbera.com/journals/jamadermatology/fullarticle/2767250 Sat, 01 Aug 2020 00:00:00 GMT This systematic review and meta-analysis assesses the association of the use of certain classes of medications among patients and the development of bullous pemphigoid. 156 8 891 900 10.1001/jamadermatol.2020.1587 2767250 //www.igerbera.com/journals/jamadermatology/fullarticle/2768743 Tue, 01 Sep 2020 00:00:00 GMT This consensus statement assesses what evidence is needed to develop guidelines on integration of gene expression profile testing into cutaneous melanoma management. 156 9 1004 1011 10.1001/jamadermatol.2020.1729 2768743 //www.igerbera.com/journals/jamadermatology/fullarticle/2770560 Sun, 01 Nov 2020 00:00:00 GMT This case-time-control analysis uses data from the French national health insurance database to assess whether the initiation of ustekinumab treatment is associated with triggering severe cardiovascular events. 156 11 1208 1215 10.1001/jamadermatol.2020.2977 2770560 //www.igerbera.com/journals/jamadermatology/fullarticle/2790344 Sun, 01 May 2022 00:00:00 GMT This epidemiological assessment uses the GLOBOCAN database to evaluate the numbers of new cases and deaths due to cutaneous melanoma globally and by world region in 2020 and to estimate global values in 2040. 158 5 495 503 10.1001/jamadermatol.2022.0160 2790344 //www.igerbera.com/journals/jamadermatology/fullarticle/2768760 Tue, 01 Sep 2020 00:00:00 GMT This case series describes livedo racemosa and retiform purpura as cutaneous findings in patients with COVID-19. 156 9 1022 1024 10.1001/jamadermatol.2020.2800 2768760 //www.igerbera.com/journals/jamadermatology/fullarticle/2772818 Fri, 01 Jan 2021 00:00:00 GMT This case-control study investigates the association of suicidality (ideation, attempt, and completed suicide) and psychological adverse events (depression and anxiety) with use of finasteride in a global database. 157 1 35 42 10.1001/jamadermatol.2020.3385 2772818 //www.igerbera.com/journals/jamadermatology/fullarticle/2774113 Mon, 01 Feb 2021 00:00:00 GMT This systematic review critically assesses and synthesizes the published data regarding the association between UV exposure and the risk of cutaneous melanoma in skin of color. 157 2 213 219 10.1001/jamadermatol.2020.4616 2774113 //www.igerbera.com/journals/jamadermatology/fullarticle/2762874 Fri, 01 May 2020 00:00:00 GMT This post hoc analysis of a randomized clinical trial examines factors associated with short-term relapse in patients with pemphigus treated with rituximab. 156 5 545 552 10.1001/jamadermatol.2020.0290 2762874

map